UniProt ID | VANG2_HUMAN | |
---|---|---|
UniProt AC | Q9ULK5 | |
Protein Name | Vang-like protein 2 | |
Gene Name | VANGL2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 521 | |
Subcellular Localization |
Cell membrane Multi-pass membrane protein. |
|
Protein Description | Involved in the control of early morphogenesis and patterning of both axial midline structures and the development of neural plate. Plays a role in the regulation of planar cell polarity, particularly in the orientation of stereociliary bundles in the cochlea. Required for polarization and movement of myocardializing cells in the outflow tract and seems to act via RHOA signaling to regulate this process. Required for cell surface localization of FZD3 and FZD6 in the inner ear (By similarity).. | |
Protein Sequence | MDTESQYSGYSYKSGHSRSSRKHRDRRDRHRSKSRDGGRGDKSVTIQAPGEPLLDNESTRGDERDDNWGETTTVVTGTSEHSISHDDLTRIAKDMEDSVPLDCSRHLGVAAGATLALLSFLTPLAFLLLPPLLWREELEPCGTACEGLFISVAFKLLILLLGSWALFFRRPKASLPRVFVLRALLMVLVFLLVVSYWLFYGVRILDARERSYQGVVQFAVSLVDALLFVHYLAVVLLELRQLQPQFTLKVVRSTDGASRFYNVGHLSIQRVAVWILEKYYHDFPVYNPALLNLPKSVLAKKVSGFKVYSLGEENSTNNSTGQSRAVIAAAARRRDNSHNEYYYEEAEHERRVRKRRARLVVAVEEAFTHIKRLQEEEQKNPREVMDPREAAQAIFASMARAMQKYLRTTKQQPYHTMESILQHLEFCITHDMTPKAFLERYLAAGPTIQYHKERWLAKQWTLVSEEPVTNGLKDGIVFLLKRQDFSLVVSTKKVPFFKLSEEFVDPKSHKFVMRLQSETSV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MDTESQYSGY -----CCCCCHHCCC | 35.92 | 27732954 | |
5 | Phosphorylation | ---MDTESQYSGYSY ---CCCCCHHCCCCC | 36.19 | 27732954 | |
7 | Phosphorylation | -MDTESQYSGYSYKS -CCCCCHHCCCCCCC | 17.22 | 27732954 | |
8 | Phosphorylation | MDTESQYSGYSYKSG CCCCCHHCCCCCCCC | 24.50 | 27732954 | |
10 | Phosphorylation | TESQYSGYSYKSGHS CCCHHCCCCCCCCCC | 11.68 | 27732954 | |
11 | Phosphorylation | ESQYSGYSYKSGHSR CCHHCCCCCCCCCCC | 29.61 | 27732954 | |
12 | Phosphorylation | SQYSGYSYKSGHSRS CHHCCCCCCCCCCCC | 10.73 | 27732954 | |
42 | Ubiquitination | RDGGRGDKSVTIQAP CCCCCCCCCEEEECC | 50.04 | - | |
43 | Phosphorylation | DGGRGDKSVTIQAPG CCCCCCCCEEEECCC | 29.27 | 25002506 | |
45 | Phosphorylation | GRGDKSVTIQAPGEP CCCCCCEEEECCCCC | 17.92 | 25002506 | |
58 | Phosphorylation | EPLLDNESTRGDERD CCCCCCCCCCCCCCC | 29.65 | 30266825 | |
59 | Phosphorylation | PLLDNESTRGDERDD CCCCCCCCCCCCCCC | 32.28 | 30266825 | |
71 | Phosphorylation | RDDNWGETTTVVTGT CCCCCCCCEEEEEEC | 24.67 | 27732954 | |
72 | Phosphorylation | DDNWGETTTVVTGTS CCCCCCCEEEEEECC | 17.19 | 30266825 | |
73 | Phosphorylation | DNWGETTTVVTGTSE CCCCCCEEEEEECCC | 22.02 | 30266825 | |
76 | Phosphorylation | GETTTVVTGTSEHSI CCCEEEEEECCCCCC | 30.33 | 30266825 | |
78 | Phosphorylation | TTTVVTGTSEHSISH CEEEEEECCCCCCCH | 22.90 | 30266825 | |
79 | Phosphorylation | TTVVTGTSEHSISHD EEEEEECCCCCCCHH | 34.36 | 30266825 | |
82 | Phosphorylation | VTGTSEHSISHDDLT EEECCCCCCCHHHHH | 23.02 | 30266825 | |
84 | Phosphorylation | GTSEHSISHDDLTRI ECCCCCCCHHHHHHH | 24.71 | 30266825 | |
89 | Phosphorylation | SISHDDLTRIAKDME CCCHHHHHHHHHHCC | 27.33 | 30266825 | |
174 | Phosphorylation | FFRRPKASLPRVFVL HHCCCCCCCCHHHHH | 45.06 | 24719451 | |
195 | Phosphorylation | LVFLLVVSYWLFYGV HHHHHHHHHHHHHHH | 11.78 | - | |
196 | Phosphorylation | VFLLVVSYWLFYGVR HHHHHHHHHHHHHHH | 8.43 | - | |
200 | Phosphorylation | VVSYWLFYGVRILDA HHHHHHHHHHHHHCH | 16.73 | - | |
258 | Phosphorylation | VRSTDGASRFYNVGH EECCCCCCCEEEECC | 28.58 | 23532336 | |
267 | Phosphorylation | FYNVGHLSIQRVAVW EEEECCHHHHHHHHH | 15.82 | 24719451 | |
279 | Phosphorylation | AVWILEKYYHDFPVY HHHHHHHHCCCCCCC | 9.17 | 26657352 | |
286 | Phosphorylation | YYHDFPVYNPALLNL HCCCCCCCCHHHHCC | 18.70 | 26657352 | |
303 | Phosphorylation | SVLAKKVSGFKVYSL HHHHHHCCCCEEEEC | 47.60 | 24719451 | |
306 | Ubiquitination | AKKVSGFKVYSLGEE HHHCCCCEEEECCCC | 43.73 | - | |
308 | Phosphorylation | KVSGFKVYSLGEENS HCCCCEEEECCCCCC | 9.96 | 25884760 | |
309 | Phosphorylation | VSGFKVYSLGEENST CCCCEEEECCCCCCC | 32.65 | - | |
315 | Phosphorylation | YSLGEENSTNNSTGQ EECCCCCCCCCCCHH | 35.47 | 24719451 | |
316 | Phosphorylation | SLGEENSTNNSTGQS ECCCCCCCCCCCHHH | 50.42 | 28348404 | |
337 | Phosphorylation | AARRRDNSHNEYYYE HHHHCCCCCCCCCCH | 31.79 | - | |
341 | Phosphorylation | RDNSHNEYYYEEAEH CCCCCCCCCCHHHHH | 19.37 | 25884760 | |
342 | Phosphorylation | DNSHNEYYYEEAEHE CCCCCCCCCHHHHHH | 9.75 | - | |
343 | Phosphorylation | NSHNEYYYEEAEHER CCCCCCCCHHHHHHH | 13.34 | - | |
379 | Ubiquitination | RLQEEEQKNPREVMD HHHHHHHHCHHHHCC | 72.67 | - | |
507 | Ubiquitination | SEEFVDPKSHKFVMR CHHHCCCCCCCHHHH | 61.81 | - | |
517 | Phosphorylation | KFVMRLQSETSV--- CHHHHHHHCCCC--- | 47.65 | 28176443 | |
519 | Phosphorylation | VMRLQSETSV----- HHHHHHCCCC----- | 39.78 | 28176443 | |
520 | Phosphorylation | MRLQSETSV------ HHHHHCCCC------ | 23.06 | 28176443 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of VANG2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VANG2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VANG2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
VANG1_HUMAN | VANGL1 | physical | 26754771 | |
SQSTM_HUMAN | SQSTM1 | physical | 26754771 | |
MK08_HUMAN | MAPK8 | physical | 26754771 | |
HSP7C_HUMAN | HSPA8 | physical | 28514442 | |
RNF41_HUMAN | RNF41 | physical | 28481871 | |
DVL1_MOUSE | Dvl1 | physical | 28481871 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
182940 | Neural tube defects (NTD) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...